tradingkey.logo

Amphastar Pharmaceuticals Enteres License Agreement With Nanjing Anji Biotechnology

ReutersAug 12, 2025 10:47 AM

- Amphastar Pharmaceuticals Inc AMPH.O:

  • AMPHASTAR PHARMACEUTICALS INC - ON AUGUST 8, ENTERED LICENSE AGREEMENT WITH NANJING ANJI BIOTECHNOLOGY - SEC FILING

  • AMPHASTAR PHARMACEUTICALS INC - TO PAY UP TO $267 MILLION IN MILESTONE PAYMENTS - SEC FILING

  • AMPHASTAR PHARMACEUTICALS INC - PAYS $6 MILLION TO ANJI UPON AGREEMENT SIGNING - SEC FILING

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI